Advertisement

Topics

STAT Plus: FDA finalizes rules for when a biosimilar is ‘interchangeable’ with a biologic

13:58 EDT 10 May 2019 | STAT

Today the FDA spelled out exactly what kind of studies biosimilar drug makers must conduct in order to be considered “interchangeable” with a biologic drug.

Original Article: STAT Plus: FDA finalizes rules for when a biosimilar is ‘interchangeable’ with a biologic

NEXT ARTICLE

More From BioPortfolio on "STAT Plus: FDA finalizes rules for when a biosimilar is ‘interchangeable’ with a biologic"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biosimilars
Biosimilars or Follow-on biologics are terms used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator product. Products that ar...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...